AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017
Mar 17, 2017
30583_dirs_2017-03-17_24c0c851-1441-45a6-b833-d3a873e061dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-03-15
Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-15 | Common Stock | F | 4301 | $92.50 | Disposed | 16460 | Direct |
| 2017-03-16 | Common Stock | S | 1989 | $91.96 | Disposed | 14471 | Direct |
Footnotes
F1: Trade made pursuant to a 10b5-1 plan executed on November 16, 2016.
F2: All shares were sold at the same price.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19